Last Updated: 31-07-2025 | Format: PDF | Report ID:20428 | Author: Manisha C
| Key Market Question | Answer |
|---|---|
| What is the market size in 2025? | $4,120 Million |
| What is the projected market size by 2035? | $6,730 Million |
| What is the market CAGR from 2025 to 2035? | 5.0% |
| Which region dominates the market? | United States (69%) |
| Which product/service type dominates the market? | Blood Collection Tubes (35%) |
| Which application leads the market? | Diagnostics (40%) |
| Who are the major buyers? | Hospitals (38%), Diagnostic Centers (26%) |
| What are the key market growth drivers? | Rise in Chronic and Infectious Diseases: The increasing incidence of chronic conditions such as diabetes and cardiovascular ailments as well as infections necessitates frequent blood testing; Technological Advancements and Automation: Technological improvements such as vacuum-assisted and automated blood collection devices enhance sample integrity and minimize human error |
| What are the major market challenges? | Stringent Regulatory Approval Processes: Regulatory hurdles can delay time-to-market for novel blood collection devices; Product Recalls and Compliance Issues: Quality concerns and device recalls can tarnish reputations and cause financial setbacks |
Study period:
2020-2035
Base year:
2026
Historical data
2020-2024
NO OF PAGE:
167
What You Get:
| What is the forecast period? |
| 2026–2035 |
| Who are the key market players? | Becton, Dickinson and Company, Terumo Corporation, Greiner Bio-One International GmbH, Fresenius Kabi AG, Haemonetics Corporation, Cardinal Health, Inc., Sarstedt AG & Co. KG, Medtronic plc, Nipro Medical Corporation, Smiths Medical, FL Medical S.R.L., Retractable Technologies, Inc., AdvaCare Pharma, Kawasumi Laboratories, Inc., ICU Medical, Inc. |
North America Needles Market Market: by Type (Syringe Needles, Suture Needles, Blood Collection Needles, Dental Needles, Insulin Needles, Ophthalmic Needles) Application (Sample Collection, Drug Delivery, Blood Collection, Vaccination, Biopsy, Others), Distribution Channels (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Clinics, Diagnostic Centers, Others), Technology (Conventional Needles, Safety Needles, Passive Safety Needles, Active Safety Needles, Hypodermic Needles, Specialty Needles), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025
North America Blood Glucose Monitoring System Market: by Type (Self-Monitoring Blood Glucose Systems, Continuous Glucose Monitoring Systems, Non-Invasive Glucose Monitoring Systems, Biosensor-Based Glucose Monitoring Systems, Smart Glucose Monitoring Devices, Implantable Glucose Monitoring Devices), Application (Hospitals, Home Care, Clinics, Diagnostic Centers, Ambulatory Surgical Centers, Others), Distribution Channels (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Direct Tenders, Distributors, Others), Technology (Electrochemical, Optical, Enzymatic, Wearable, Non-Invasive, Smart Technology), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025
Global Biosimilars Treatment Market: by Type (Monoclonal Antibodies, Recombinant Hormones, Fusion Proteins, Immunomodulators, Insulins, Erythropoietin), Application (Oncology, Autoimmune Diseases, Chronic Diseases, Blood Disorders, Infectious Diseases, Other Applications), Distribution Channels (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Specialty Clinics, Drug Stores, Others), Technology (Recombinant DNA Technology, Monoclonal Antibody Technology, Genomics, Proteomics, Bioengineering, Others), Organization Size (Small, Medium, Large) and By Global – Historical & Forecast Period (2020-2035) Comprehensive Study 2025
Global Digital Biomarkers Market: by Type (Wearable Devices, Mobile Health Apps, Biosensors, Clinical Trials Platforms, Digital Diagnostics, Passive Monitoring Systems), Application (Cardiovascular Disease, Neurodegenerative Disorders, Diabetes, Respiratory Disease, Oncology, Others), Distribution Channels (Hospitals, Clinics, Research Centers, Homecare, Pharmacies, Online), Technology (Artificial Intelligence, Internet of Things, Machine Learning, Cloud Computing, Blockchain, Data Analytics), Organization Size (Small, Medium, Large) and By Global – Historical & Forecast Period (2020-2035) Comprehensive Study 2025
Global Residual DNA Testing Market: by Type (qPCR-based Residual DNA Testing, PCR-based Residual DNA Testing, DNA Hybridization, ELISA-based Residual DNA Testing, Others), Application (Biopharmaceuticals, Vaccines, Gene Therapy, Cell Therapy, Blood and Plasma Products, Others), Distribution Channels (Direct Sales, Distributors, Online Sales, Others), Technology (qPCR, PCR, Hybridization, ELISA, Capillary Electrophoresis, Others), Organization Size (Small, Medium, Large) and By Global – Historical & Forecast Period (2020-2035) Comprehensive Study 2025